A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism (ASPIRE)

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Primary study
Registry of TrialsANZCTR
Year 2005

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ASPIRE [Aspirin to Prevent Recurrent Venous Thromboembolism] (4 documents)
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: a125dec49b17464900d955b548562507c262efe7
First added on: Apr 23, 2018